Comparison 4.
Aspirin 900 mg plus metoclopramide 10 mg versus active comparator
| Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
|---|---|---|---|---|
| 1 Headache relief at 2 hours | 2 | Risk Ratio (M-H, Fixed, 95% CI) | Subtotals only | |
| 1.1 Sumartiptan 100 mg | 2 | 523 | Risk Ratio (M-H, Fixed, 95% CI) | 0.93 [0.79, 1.10] |
| 2 Pain free at 2 hours | 2 | Risk Ratio (M-H, Fixed, 95% CI) | Subtotals only | |
| 2.1 Sumatriptan 100 mg | 2 | 528 | Risk Ratio (M-H, Fixed, 95% CI) | 0.63 [0.45, 0.87] |
| 3 Relief of associated symptoms at 2 hours | 2 | Risk Ratio (M-H, Fixed, 95% CI) | Subtotals only | |
| 3.1 Nausea | 2 | 410 | Risk Ratio (M-H, Fixed, 95% CI) | 1.10 [0.83, 1.46] |
| 3.2 Vomiting | 2 | 67 | Risk Ratio (M-H, Fixed, 95% CI) | 10.59 [1.43, 78.64] |
| 4 Persistence of associated symptoms after 2 hours | 2 | Risk Ratio (M-H, Fixed, 95% CI) | Subtotals only | |
| 4.1 Nausea | 2 | 612 | Risk Ratio (M-H, Fixed, 95% CI) | 0.99 [0.83, 1.19] |
| 4.2 Vomiting | 2 | 608 | Risk Ratio (M-H, Fixed, 95% CI) | 0.63 [0.39, 1.02] |